Enterin
Philadelphia, US · Founded 2014 · Delaware corporation · 2 known investors
Find your way into Enterin
Sign up to see every warm intro you have to Enterin
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Enterin team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Enterin was founded in 2014 by Denise Barbut and Michael Zasloff.
Board
MF

Investors · 2
Scientia Ventureslisted by Scientia VenturesNew York
How we know: Scientia Ventures's portfolio page · Not right? Tell us
VoLo Earth VenturesreportedSnowmass Village · $2M
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$50.7M disclosed across 6 rounds · 2017–2023
▶$5.1MraisedDec 2023 · 4 investors · BiotechnologyRule 506(b)
▶$5.1MraisedDec 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael ZasloffDirector
- David McCulloughExecutive Officer, Director
- Barry MillerDirector
- Don MunozDirector
- Katherine WolfExecutive Officer
- Richard LarsonExecutive Officer
- Roger MillsDirector
- William KinneyExecutive Officer
- Jay A BrammerDirector
- Richard PropperDirector
- Mark FinnDirector
- Offering amount
- $20M
- Amount sold
- $5.1M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedSep 2022 · 3 investors · BiotechnologyRule 506(b)
▶$6MraisedSep 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael ZasloffExecutive Officer, Director
- Denise BarbutExecutive Officer, Director
- Richard PropperDirector
- Jay A BrammerDirector
- Don MunozDirector
- David McCulloughExecutive Officer, Director
- Mark FinnDirector
- David VogelDirector
- Katherine WolfExecutive Officer
- Roger MillsDirector
- Offering amount
- $20M
- Amount sold
- $6M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.7MraisedOct 2021 · 2 investors · BiotechnologyRule 506(b)
▶$5.7MraisedOct 2021 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard PropperDirector
- Katherine WolfExecutive Officer, Director
- Denise BarbutExecutive Officer, Director
- Jay A BrammerDirector
- Mark FinnDirector
- Roger MillsDirector
- David McCulloughExecutive Officer, Director
- Don MunozDirector
- Michael ZasloffExecutive Officer, Director
- Offering amount
- $32M
- Amount sold
- $5.7M
- Minimum investment
- $1M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.7MraisedSep 2020 · 9 investors · Other Health CareRule 506(b)
▶$11.7MraisedSep 2020 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard PropperDirector
- Jay BrammerExecutive Officer, Director
- Denise BarbutExecutive Officer, Director
- Mark FinnDirector
- Stuart BarlowExecutive Officer
- Michael ZasloffExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $11.7M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.7MraisedJan 2019 · 6 investors · PharmaceuticalsRule 506(b)
▶$16.7MraisedJan 2019 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Nancy NessExecutive Officer
- Michael ZasloffExecutive Officer, Director
- Denise BarbutExecutive Officer, Director
- Jay A. BrammerDirector
- Richard PropperDirector
- Mark FinnDirector
- Offering amount
- $25M
- Amount sold
- $16.7M
- Proceeds to insiders
- $433K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$5.5MraisedJul 2017 · 21 investors · PharmaceuticalsRule 506(b)
▶$5.5MraisedJul 2017 · 21 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard PropperDirector
- Denise BarbutExecutive Officer, Director
- Mark FinnDirector
- Michael ZasloffExecutive Officer, Director
- Offering amount
- $12.7M
- Amount sold
- $5.5M
- Proceeds to insiders
- $433K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Enterin?
- Enterin was founded by Denise Barbut, Michael Zasloff in 2014.
- Who are Enterin's investors?
- Enterin's investors include Scientia Ventures, VoLo Earth Ventures.
- How much funding has Enterin raised?
- Enterin has disclosed $50.7M raised across 6 rounds.
- Where is Enterin headquartered?
- Enterin is headquartered in Philadelphia, US.